Collegium Pharmaceutical Inc (NASDAQ:COLL)
| 18.17 Delayed Data As of Jul 01 |  +0.45 / +2.54%Today’s Change | 14.04 Today|||52-Week Range 25.63 | -2.73% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Ciaffoni Joseph J President & Chief Executive Officer |  Sale | 3/01/2022 | 65,083 | $18.37 | $1.2M | -1.89% |
Ciaffoni Joseph J President & Chief Executive Officer | Sale | 2/10/2022 | 28,843 | $17.63 | $508.5K | +3.01% |
Ciaffoni Joseph J President & Chief Executive Officer | Sale | 2/10/2022 | 24,154 | $17.63 | $425.8K | +3.01% |
Dreyer Scott Chief Commercial Officer & EVP | Sale | 2/18/2022 | 10,559 | $21.61 | $228.2K | -16.51% |
Ciaffoni Joseph J President & Chief Executive Officer | Sale | 3/01/2022 | 11,011 | $19.04 | $209.6K | -1.89% |
Kuhlmann Shirley R General Counsel & Executive Vice President | Sale | 2/10/2022 | 6,967 | $17.63 | $122.8K | +3.01% |
Dreyer Scott Chief Commercial Officer & EVP | Sale | 2/10/2022 | 6,643 | $17.63 | $117.1K | +3.01% |
Dreyer Scott Chief Commercial Officer & EVP | Sale | 12/15/2021 | 5,693 | $18.33 | $104.4K | -2.63% |
Malamut Richard Chief Medical Officer & Executive Vice President | Sale | 2/10/2022 | 4,462 | $17.63 | $78.7K | +3.01% |
Kuhlmann Shirley R General Counsel & Executive Vice President | Sale | 2/10/2022 | 4,212 | $17.63 | $74.3K | +3.01% |
Page of 5